In summary, this study establishes piR-hsa-8393202 and piR-hsa-8429916 as robust, tumor-derived, and functionally relevant circulating biomarkers for LUAD detection and IPN stratification. This evidence concerns the gene PIR and bile duct papillary neoplasm.